RE: Praluent (Alirocumab)-Induced Renal Injury

Autor:	Rosenson, Robert S, Larrey, Dominique, Waters, David D, Olsson, Anders G, Members of the Phase 3 Data Monitoring Committee for PRALUENT
Jazyk:	angličtina
Rok vydání:	2018
Předmět:	Cholesterol Monoclonal Members of the Phase 3 Data Monitoring Committee for PRALUENT acute renal injury Humans alirocumab Pharmacology & Pharmacy Kidney rosuvastatin Antibodies LDL
Zdroj:	Rosenson, Robert S; Larrey, Dominique; Waters, David D; Olsson, Anders G; & Members of the Phase 3 Data Monitoring Committee for PRALUENT,. (2018). RE: Praluent (Alirocumab)-Induced Renal Injury.. Journal of pharmacy practice, 31(2), 138-139. doi: 10.1177/0897190017734429. UCSF: Retrieved from: http://www.escholarship.org/uc/item/5sv5h39c Journal of pharmacy practice, vol 31, iss 2
DOI:	10.1177/0897190017734429.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::085ae282ac319bad893d2d819cbc80fc http://www.escholarship.org/uc/item/5sv5h39c Zobrazit plný text záznamu